Patents by Inventor Marina Lee Gerton

Marina Lee Gerton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaginal Hydrogel for Delivery of Therapeutics
    Publication number: 20240122850
    Abstract: The composition is a hydrogel which may be used to deliver therapeutics vaginally. The hydrogel may include a glycosaminoglycan. The glycosaminoglycan may include multiple thiol groups. The composition may also include a molecule that includes at least two thiol reactive sites. The composition may include a mucoadhesive agent as well as a therapeutic agent. The composition may deliver the therapeutic at a pH that is optimal for the vaginal environment, namely between about 3.5 and 5.0.
    Type: Application
    Filed: June 6, 2023
    Publication date: April 18, 2024
    Inventors: Marina Lee Gerton, Brenda K. Mann
  • Vaginal hydrogel for delivery of therapeutics
    Patent number: 11701324
    Abstract: The composition is a hydrogel which may be used to deliver therapeutics vaginally. The hydrogel may include a glycosaminoglycan. The glycosaminoglycan may include multiple thiol groups. The composition may also include a molecule that includes at least two thiol reactive sites. The composition may include a mucoadhesive agent as well as a therapeutic agent. The composition may deliver the therapeutic at a pH that is optimal for the vaginal environment, namely between about 3.5 and 5.0.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: July 18, 2023
    Inventors: Marina Lee Gerton, Brenda K. Mann
  • Vaginal Hydrogel for Delivery of Therapeutics
    Publication number: 20210169797
    Abstract: The composition is a hydrogel which may be used to deliver therapeutics vaginally. The hydrogel may include a glycosaminoglycan. The glycosaminoglycan may include multiple thiol groups. The composition may also include a molecule that includes at least two thiol reactive sites. The composition may include a mucoadhesive agent as well as a therapeutic agent. The composition may deliver the therapeutic at a pH that is optimal for the vaginal environment, namely between about 3.5 and 5.0.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 10, 2021
    Inventors: Marina Lee Gerton, Brenda K. Mann
  • Vaginal hydrogel for delivery of therapeutics
    Patent number: 10959945
    Abstract: The composition is a hydrogel which may be used to deliver therapeutics vaginally. The hydrogel may include a glycosaminoglycan. The glycosaminoglycan may include multiple thiol groups. The composition may also include a molecule that includes at least two thiol reactive sites. The composition may include a mucoadhesive agent as well as a therapeutic agent. The composition may deliver the therapeutic at a pH that is optimal for the vaginal environment, namely between about 3.5 and 5.0.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: March 30, 2021
    Inventors: Marina Lee Gerton, Brenda K. Mann
  • VAGINAL HYDROGEL FOR DELIVERY OF THERAPEUTICS
    Publication number: 20190290582
    Abstract: The composition is a hydrogel which may be used to deliver therapeutics vaginally. The hydrogel may include a glycosaminoglycan. The glycosaminoglycan may include multiple thiol groups. The composition may also include a molecule that includes at least two thiol reactive sites. The composition may include a mucoadhesive agent as well as a therapeutic agent. The composition may deliver the therapeutic at a pH that is optimal for the vaginal environment, namely between about 3.5 and 5.0.
    Type: Application
    Filed: December 27, 2018
    Publication date: September 26, 2019
    Inventors: Marina Lee Gerton, Brenda K. Mann